Voronoi, Inc.
KOE: 310210.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Daekwon Kim
- Employees
- 130
- Headquarters
- Incheon, Romania
- IPO year
- 2022
- Market cap
- ₩5.1T
- Website
- https://voronoi.io
Loading 310210…
Loading profile data…Frequently asked questions about 310210
What does Voronoi, Inc. (310210.KQ) do?
Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast...
Where does 310210.KQ trade?
Voronoi, Inc. (310210.KQ) trades on the KOSDAQ.
What sector is 310210.KQ in?
Voronoi, Inc. (310210.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Voronoi, Inc.?
Daekwon Kim is the chief executive officer of Voronoi, Inc. (310210.KQ).
Where is Voronoi, Inc. headquartered?
Voronoi, Inc. is headquartered in Romania.
Does 310210.KQ pay a dividend?
Voronoi, Inc. (310210.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 310210.KQ go public?
Voronoi, Inc. (310210.KQ) completed its initial public offering in 2022.